Performance of the abbott realtime HCV genotype II RUO assay

Journal of Clinical Microbiology

Volumn 50, Issue 9, 2012, Pages 3099-3101

  Shinol, Rebecca C ^a   Gale, Howard B ^a   Kan, Virginia L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

5' UNTRANSLATED REGION; ABBOTT REALTIME HCV GENOTYPE II RUO ASSAY; ANALYTICAL EQUIPMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDITY; VERSANT LIPA HCV GENOTYPE RUO ASSAY; VIRUS CULTURE;

AUTOMATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; TIME FACTORS; VIROLOGY;

EID: 84865157684     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01249-12     Document Type: Article

References (14)

1. Armstrong G, et al. 2006. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144:705-714. (Pubitemid 46780630)
2. Bacon BR, et al. 2011. Boceprevir for previously treated chronic HCV genotype 1 infection. N. Engl. J. Med. 364:1207-1217.
3. Butt AA, Kanwal F. 2012. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. Clin. Infect. Dis. 54:96-104.
4. Ciotti M, et al. 2010. A multicenter evaluation of the Abbott RealTime HCV Genotype II assay. J. Virol. Methods 167:205-207.
5. Dominitz JA, et al. 2005. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 41:88-96. (Pubitemid 40066386)
6. Jacobson IM, et al. 2011. Telaprevir for previously untreated chronic hepatitis C virus infection. N. Engl. J. Med. 364:2405-2416.
7. Lim JK. 2001. Natural history of hepatitis C infection: a concise review. Yale J. Biol. Med. 74:229-237. (Pubitemid 33010059)
8. Poordad F, et al. 2011. Boceprevir for untreated chronic HCV genotype 1 infection. N. Engl. J. Med. 364:1195-1206.
9. Population Health Group. 2012. HCV Registry veterans in care in 2011, for the nation, by VISN and by station. U.S. Department of Veterans Affairs, Office of Public Health Clinical Case Registry for Hepatitis C, Washington, DC.
10. Shinol RC, Gale HC, Kan VL. 2012. Abstr. 28th Ann. Clin. Virol. Symp.- Ann. Meet. Pan Am. Soc. Clin. Virol., Daytona Beach, FL, abstr M40.
11. Smith DB, et al. 1995. Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J. Gen. Virol. 76:1749-1761.
12. Sohn YH, Ko SY, Kim MH, Oh HB. 2010. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping. Clin. Chem. Lab. Med. 48:469-474.
13. Yee HS, et al. 2012. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am. J. Gastroenterol. 107:669-689.
14. Zeuzem S, et al. 2011. Telaprevir for retreatment of HCV infection. N. Engl. J. Med. 364:2417-2428.